MedTrace Logo

Cardiovascular Risk Assesment in Diabetic Patients Via Lens Autofluorecscence Detection

NCT02947555 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 420

Last updated 2019-02-25

No results posted yet for this study

Summary

The rate of lens autofluorescence will be compared in diabetic and non diabetic patients with/without atherosclerotic vascular diseases to evaluate if it is associated with the risk of cardiovascular diseases.

Conditions

  • Diabetic Patients With/Without Atherosclerotic Diseases

Interventions

OTHER

Non interventional

Sponsors & Collaborators

  • Bajcsy-Zsilinszky Kórház

    collaborator UNKNOWN

  • Petz Aladar County Teaching Hospital

    collaborator OTHER

  • Vanderlich Egészségcentrum

    collaborator UNKNOWN

  • Semmelweis University Heart and Vascular Center

    collaborator OTHER

  • Polytech Hungaria Kft.

    collaborator UNKNOWN

  • Dr. Gergő Molnár

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02947555 on ClinicalTrials.gov